BANK OF AMERICA CORP /DE/ - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$0450.0%0.00%
Q4 2017$0450.0%0.00%
Q3 2017$0450.0%0.00%
Q2 2017$0450.0%0.00%
Q1 2017$0450.0%0.00%
Q4 2016$0450.0%0.00%
Q3 2016$0450.0%0.00%
Q2 2016$0450.0%0.00%
Q1 2016$0450.0%0.00%
Q4 2015$0
-100.0%
45
-94.2%
0.00%
Q3 2015$6,000
-60.0%
776
-52.8%
0.00%
Q2 2015$15,0000.0%1,6450.0%0.00%
Q1 2015$15,0001,645
+3555.6%
0.00%
Q4 2014$0
-100.0%
45
-99.6%
0.00%
Q3 2014$107,000
-61.4%
12,011
-65.9%
0.00%
Q2 2014$277,000
+20.4%
35,265
+21.3%
0.00%
Q1 2014$230,00029,065
+44615.4%
0.00%
Q4 2013$0
-100.0%
65
-75.5%
0.00%
Q3 2013$1,000265
+1225.0%
0.00%
Q2 2013$0200.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,918,722$6,006,0004.90%
Tamarack Advisers, LP 4,400,000$13,882,0002.18%
AlphaOne Investment Services, LLC 580,965$1,824,0000.60%
CLOUGH CAPITAL PARTNERS L P 3,061,064$9,581,0000.50%
Rock Springs Capital Management LP 1,200,000$3,751,0000.24%
TURNER INVESTMENTS LLC 150,000$470,0000.16%
WESTFIELD CAPITAL MANAGEMENT CO LP 5,397,007$16,893,0000.14%
SABBY MANAGEMENT, LLC 484,505$1,521,0000.06%
PUTNAM INVESTMENTS LLC 3,673,622$11,536,0000.03%
ARDSLEY ADVISORY PARTNERS LP 28,900$90,0000.01%
View complete list of CARDIOME PHARMA CORP shareholders